Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
EVMN
Stock Latest News
Ratings
Matt Phipps Reiterates Buy on Evommune as EVO301 Data Strengthen IL‑18 Blockade Thesis and Support Blockbuster Potential
2d ago
EVMN
Premium
The Fly
Evommune price target raised to $55 from $54 at Morgan Stanley
6d ago
EVMN
Premium
Ratings
Evommune Earns Buy Rating on Late-Stage Pipeline Progress and Multiple Near-Term Clinical Catalysts
9d ago
EVMN
Premium
The Fly
Evommune reports Q1 EPS (64c), consensus (71c)
9d ago
EVMN
Premium
Company Announcements
Evommune Highlights Q1 Results and Advancing Inflammation Pipeline
9d ago
8K
EVMN
Premium
The Fly
Evommune initiated with a Buy at Stifel
16d ago
EVMN
Premium
Company Announcements
Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis
22d ago
EVMN
Premium
The Fly
Six new option listings on April 23rd
24d ago
GRO
ALOY
Premium
Ratings
Evommune: Differentiated MRGPRX2 Strategy and Upcoming EVO756 Phase IIb Readout Support Buy Rating
1M ago
EVMN
Premium
Company Announcements
Evommune Spotlights EVO756 as Novel Preventive Migraine Therapy
1M ago
8K
EVMN
Premium
The Fly
Evommune assumed with an Outperform at Oppenheimer
1M ago
EVMN
Premium
Market News
3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts
2M ago
UAL
EVMN
Premium
The Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
2M ago
CF
EXR
Premium
Ratings
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise
2M ago
EVMN
Premium
The Fly
Evommune price target lowered to $50 from $65 at H.C. Wainwright
2M ago
EVMN
Premium
The Fly
Evommune initiated with a Buy at Clear Street
2M ago
EVMN
Premium
The Fly
Evommune initiated with an Outperform at RBC Capital
2M ago
EVMN
Premium
Company Announcements
Evommune Reports Q4 2025 Results and Pipeline Progress
2M ago
8K
EVMN
Premium
The Fly
Evommune reports Q4 EPS ($1.43), consensus (84c)
2M ago
EVMN
Premium
Ratings
Evommune, Inc.: Lead in MRGPRX2 Modulation and Differentiated EVO756 Profile Support Buy Rating
2M ago
EVMN
Premium
Ratings
Evommune: Validating External Data and Pipeline Lead Position Support Buy Rating and Upside Potential
3M ago
EVMN
Premium
The Fly
Evommune price target raised to $54 from $36 at Morgan Stanley
3M ago
EVMN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
